A meta-analytic evaluation of the efficacy and safety of levetiracetam for treating myoclonic seizures
Levetiracetam (LEV) is a broad-spectrum antiseizure medication that is effective and safe in myoclonic seizures. This study aims to systematically review and meta-analyze the literature using LEV in myoclonic seizures and its efficacy and safety profile.The included literature is updated till Februa...
Saved in:
Main Authors: | Sara Najafi, Mohaddeseh Sadat Alavi, Hamid Reza Sadeghnia |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-02-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844025006243 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical and genetic analysis of epilepsy with myoclonic-atonic seizures caused by SLC6A1 gene variant
by: Zhen Li, et al.
Published: (2025-01-01) -
Characteristics and clinical course of myoclonus in Cavalier King Charles Spaniels
by: Matthew James, et al.
Published: (2025-01-01) -
Antiseizure medications and their differing effects on cardiovascular risk
by: Aleena Abbasi, et al.
Published: (2025-03-01) -
Myoclonus
by: R. Rimšienė, et al.
Published: (2020-12-01) -
A multicenter, cross‐sectional analysis to assess the safety and usage pattern of brivaracetam in the management of partial‐onset seizure with BAEs—BREEZE study: A post‐hoc analysis
by: Arvind Sharma, et al.
Published: (2025-02-01)